Imatinib might constitute a treatment option for lung involvement in COVID-19

Authors :: Ana Isabel Farfán-Sedano
Virginia García-Bermúdez
Cristina Lucía De Ancos-Aracil
Beatriz Jaenes-Barrios
Juan Víctor San Martín-López
Mario García-Gil
Fernando Bermejo
David Bernal-Bello
José Manuel Ruiz-Giardín
Alejandro Morales-Ortega
Begoña Frutos-Pérez
A. Zapatero-Gaviria
Source :: Autoimmunity Reviews
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
business.industry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Immunology
Treatment options
Imatinib
medicine.disease
Lung involvement
Article
Pneumonia
Imatinib mesylate
Internal medicine
medicine
Immunology and Allergy
business
Coronavirus Infections
medicine.drug

Full Text Access

Tools